Literature DB >> 33994899

Recent Advances in Nanoscale Metal-Organic Frameworks Towards Cancer Cell Cytotoxicity: An Overview.

Pierre D Harvey1, Jessica Plé1.   

Abstract

Abstract: The fight against cancer has always been a prevalent research topic. Nanomaterials have the ability to directly penetrate cancer cells and potentially achieve minimally invasive, precise and efficient tumor annihilation. As such, nanoscale metal organic frameworks (nMOFs) are becoming increasingly attractive as potential therapeutic agents in the medical field due to their high structural variability, good biocompatibility, ease of surface functionalization as well as their porous morphologies with tunable cavity sizes. This overview addresses five different common strategies used to find cancer therapies, while summarizing the recent progress in using nMOFs as cytotoxic cancer cell agents largely through in vitro studies, although some in vivo investigations have also been reported. Chemo and targeted therapies rely on drug encapsulation and delivery inside the cell, whereas photothermal and photodynamic therapies depend on photosensitizers. Concurrently, immunotherapy actively induces the body to destroy the tumor by activating an immune response. By choosing the appropriate metal center, ligands and surface functionalization, nMOFs can be utilized in all five types of therapies. In the last section, the future prospects and challenges of nMOFs with respect to the various therapies will be presented and discussed.
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.

Entities:  

Year:  2021        PMID: 33994899      PMCID: PMC8114195          DOI: 10.1007/s10904-021-02011-3

Source DB:  PubMed          Journal:  J Inorg Organomet Polym Mater        ISSN: 1574-1443            Impact factor:   3.518


  163 in total

Review 1.  Intrinsic Resistance of Solid Tumors to Immune Checkpoint Blockade Therapy.

Authors:  Xianda Zhao; Subbaya Subramanian
Journal:  Cancer Res       Date:  2017-02-03       Impact factor: 12.701

2.  Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Kevin C Gatter; Adrian L Harris
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

3.  Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.

Authors:  Shen-Zhen Ren; Dan Zhu; Xiao-Hua Zhu; Bin Wang; Yu-Shun Yang; Wen-Xue Sun; Xiao-Ming Wang; Peng-Cheng Lv; Zhong-Chang Wang; Hai-Liang Zhu
Journal:  ACS Appl Mater Interfaces       Date:  2019-05-28       Impact factor: 9.229

Review 4.  The recent progress on metal-organic frameworks for phototherapy.

Authors:  Qiyao Zheng; Xiangmei Liu; Yufeng Zheng; Kelvin W K Yeung; Zhenduo Cui; Yanqin Liang; Zhaoyang Li; Shengli Zhu; Xianbao Wang; Shuilin Wu
Journal:  Chem Soc Rev       Date:  2021-04-26       Impact factor: 54.564

5.  Combined Fenton and starvation therapies using hemoglobin and glucose oxidase.

Authors:  Hadi Ranji-Burachaloo; Amin Reyhani; Paul A Gurr; Dave E Dunstan; Greg G Qiao
Journal:  Nanoscale       Date:  2019-03-21       Impact factor: 7.790

Review 6.  Role of the mammalian ATG8/LC3 family in autophagy: differential and compensatory roles in the spatiotemporal regulation of autophagy.

Authors:  You-Kyung Lee; Jin-A Lee
Journal:  BMB Rep       Date:  2016-08       Impact factor: 4.778

Review 7.  Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?

Authors:  Zhe Li; Qin Li; Jun Wu; Manyuan Wang; Junxian Yu
Journal:  Molecules       Date:  2016-10-07       Impact factor: 4.411

Review 8.  Bioengineering of Metal-organic Frameworks for Nanomedicine.

Authors:  Yuan Liu; Yanli Zhao; Xiaoyuan Chen
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

9.  Assessment of the evolution of cancer treatment therapies.

Authors:  Manuel Arruebo; Nuria Vilaboa; Berta Sáez-Gutierrez; Julio Lambea; Alejandro Tres; Mónica Valladares; Africa González-Fernández
Journal:  Cancers (Basel)       Date:  2011-08-12       Impact factor: 6.639

Review 10.  pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment.

Authors:  Ke-Ni Yang; Chun-Qiu Zhang; Wei Wang; Paul C Wang; Jian-Ping Zhou; Xing-Jie Liang
Journal:  Cancer Biol Med       Date:  2014-03       Impact factor: 4.248

View more
  1 in total

Review 1.  Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy.

Authors:  Su-Ran Li; Fang-Yi Huo; Han-Qi Wang; Jing Wang; Chun Xu; Bing Liu; Lin-Lin Bu
Journal:  J Nanobiotechnology       Date:  2022-06-14       Impact factor: 9.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.